External
Repatriation Medical Authority Statement

Hepatitis C - Blood transfusion Factor

Last reviewed for CCPS 30 April 1997.

Investigative Documents

Claimant Report - Transfusion of Blood or Blood Products [CR9012]

Medical Report - Blood Transfusion and Injection of Blood Products - Hepatitis [MR9051]

Preliminary questions [10230]

12034

there is some evidence that a blood transfusion may be a factor in the development of the condition under consideration.

2355 the veteran has had a blood transfusion at some time.

10241

the veteran had a blood transfusion more than 2 weeks before the clinical onset of hepatitis C.

10243the blood transfusion more than 2 weeks before the clinical onset of hepatitis C was given for treatment of an illness or injury which is identifiable. [Default true]

10242

the blood transfusion more than 2 weeks before the clinical onset of hepatitis C, which was given for treatment of the identified illness or injury, was screened for hepatitis C.

10244the veteran has established the causal connection between the identified illness or injury which required the blood transfusion and VEA service for the clinical onset of hepatitis C.

10247the veteran has established the causal connection between the identified illness or injury which required the blood transfusion and operational service for the clinical onset of hepatitis C.

or

10248the veteran has established the causal connection between the identified illness or injury which required the blood transfusion and eligible service for the clinical onset of hepatitis C.

Clinical onset and operational service [10247]

2362the identified illness or injury for which the blood transfusion was given is causally related to operational service.

Clinical onset and eligible service [10248]

2363the identified illness or injury for which the blood transfusion was given is causally related to eligible service.